Gene therapy: Suppressing seizures

Nature Reviews Drug Discovery

Volumn 12, Issue 1, 2013, Pages 22-

  Faruqi, Mariam ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HALORHODOPSIN; LENTIVIRUS VECTOR; POTASSIUM CHANNEL KV1.1; TETANUS TOXIN;

BRAIN REGION; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FOCAL EPILEPSY; FOCAL NEOCORTICAL EPILEPSY; GENE; GENE OVEREXPRESSION; HALORHODOPSIN GENE; HUMAN; MOTOR CORTEX; NONHUMAN; NOTE; POTASSIUM CHANNEL KV1.1 GENE; PRIORITY JOURNAL; SEIZURE; VIRAL GENE THERAPY;

ANIMALS; EPILEPSIES, PARTIAL; GENETIC THERAPY; KV1.1 POTASSIUM CHANNEL; MALE; NEOCORTEX; OPTOGENETICS;

EID: 84871879972     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3918     Document Type: Note

References (1)

1. Wykes, R. C. et al. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci. Transl. Med. 4, 161ra152 (2012)